Seres Therapeutics Inc
F:1S9
Income Statement
Earnings Waterfall
Seres Therapeutics Inc
Income Statement
Seres Therapeutics Inc
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
7
|
9
|
0
|
2
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
6
+111%
|
19
+228%
|
22
+16%
|
22
+1%
|
22
+0%
|
32
+45%
|
32
+0%
|
33
+3%
|
35
+5%
|
21
-40%
|
28
+37%
|
32
+12%
|
40
+25%
|
38
-5%
|
35
-8%
|
35
+3%
|
29
-18%
|
23
-19%
|
33
+43%
|
31
-7%
|
30
-3%
|
155
+418%
|
145
-7%
|
141
-3%
|
137
-3%
|
13
-90%
|
0
N/A
|
4
N/A
|
129
+3 027%
|
126
-3%
|
0
N/A
|
126
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(10)
|
(15)
|
(22)
|
(31)
|
(42)
|
(55)
|
(69)
|
(88)
|
(106)
|
(115)
|
(121)
|
(121)
|
(119)
|
(123)
|
(127)
|
(128)
|
(129)
|
(129)
|
(127)
|
(117)
|
(110)
|
(105)
|
(102)
|
(105)
|
(113)
|
(121)
|
(135)
|
(161)
|
(188)
|
(209)
|
(226)
|
(237)
|
(241)
|
(180)
|
(199)
|
(211)
|
(195)
|
(189)
|
(195)
|
(149)
|
(139)
|
(118)
|
(117)
|
(110)
|
(104)
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(6)
|
(9)
|
(13)
|
(17)
|
(21)
|
(27)
|
(30)
|
(33)
|
(34)
|
(34)
|
(34)
|
(34)
|
(34)
|
(34)
|
(34)
|
(33)
|
(31)
|
(28)
|
(26)
|
(25)
|
(23)
|
(24)
|
(26)
|
(31)
|
(36)
|
(47)
|
(59)
|
(69)
|
(76)
|
(79)
|
(78)
|
(70)
|
(74)
|
(82)
|
(83)
|
(75)
|
(76)
|
(64)
|
(58)
|
(53)
|
(53)
|
(47)
|
(44)
|
|
| Research & Development |
(7)
|
(11)
|
(15)
|
(22)
|
(29)
|
(38)
|
(48)
|
(61)
|
(76)
|
(82)
|
(87)
|
(88)
|
(86)
|
(89)
|
(93)
|
(94)
|
(95)
|
(96)
|
(95)
|
(89)
|
(84)
|
(80)
|
(79)
|
(81)
|
(87)
|
(91)
|
(98)
|
(114)
|
(130)
|
(142)
|
(152)
|
(160)
|
(163)
|
(110)
|
(114)
|
(117)
|
(99)
|
(114)
|
(114)
|
(85)
|
(76)
|
(62)
|
(59)
|
(54)
|
(50)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
2
|
0
|
0
|
(11)
|
(13)
|
(13)
|
0
|
(5)
|
0
|
(5)
|
(4)
|
(4)
|
(9)
|
(9)
|
|
| Operating Income |
(10)
N/A
|
(15)
-54%
|
(22)
-43%
|
(31)
-45%
|
(42)
-35%
|
(55)
-30%
|
(67)
-21%
|
(82)
-24%
|
(87)
-6%
|
(93)
-7%
|
(99)
-6%
|
(99)
0%
|
(87)
+12%
|
(91)
-5%
|
(94)
-3%
|
(93)
+0%
|
(108)
-16%
|
(100)
+7%
|
(95)
+5%
|
(78)
+18%
|
(73)
+6%
|
(70)
+3%
|
(67)
+5%
|
(77)
-14%
|
(89)
-17%
|
(88)
+1%
|
(104)
-18%
|
(131)
-27%
|
(33)
+75%
|
(64)
-96%
|
(85)
-32%
|
(100)
-18%
|
(228)
-127%
|
(180)
+21%
|
(195)
-8%
|
(82)
+58%
|
(69)
+16%
|
(189)
-175%
|
(68)
+64%
|
(149)
-118%
|
(139)
+7%
|
(118)
+15%
|
(117)
+1%
|
(110)
+6%
|
(103)
+6%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
(0)
|
(1)
|
(2)
|
(2)
|
(1)
|
(0)
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(0)
|
5
|
0
|
(1)
|
(3)
|
4
|
(1)
|
2
|
2
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(7)
|
(7)
|
(5)
|
0
|
(21)
|
35
|
35
|
62
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
2
|
6
|
6
|
(17)
|
9
|
16
|
19
|
45
|
|
| Pre-Tax Income |
(10)
N/A
|
(17)
-59%
|
(23)
-38%
|
(33)
-43%
|
(43)
-32%
|
(55)
-26%
|
(67)
-21%
|
(82)
-23%
|
(86)
-5%
|
(92)
-7%
|
(97)
-6%
|
(97)
0%
|
(86)
+12%
|
(89)
-4%
|
(92)
-3%
|
(92)
+0%
|
(107)
-16%
|
(99)
+7%
|
(95)
+4%
|
(78)
+18%
|
(73)
+7%
|
(70)
+3%
|
(66)
+6%
|
(76)
-15%
|
(90)
-18%
|
(89)
+1%
|
(105)
-17%
|
(132)
-26%
|
(34)
+74%
|
(66)
-94%
|
(87)
-32%
|
(103)
-19%
|
(231)
-124%
|
(184)
+21%
|
(198)
-8%
|
(87)
+56%
|
(68)
+22%
|
(190)
-180%
|
(69)
+64%
|
(149)
-115%
|
(159)
-7%
|
(126)
+21%
|
(67)
+47%
|
(54)
+19%
|
5
N/A
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(10)
|
(17)
|
(23)
|
(33)
|
(43)
|
(55)
|
(67)
|
(82)
|
(86)
|
(92)
|
(97)
|
(97)
|
(86)
|
(89)
|
(92)
|
(92)
|
(107)
|
(99)
|
(95)
|
(78)
|
(73)
|
(70)
|
(66)
|
(76)
|
(90)
|
(89)
|
(105)
|
(132)
|
(34)
|
(66)
|
(87)
|
(103)
|
(231)
|
(184)
|
(198)
|
(87)
|
(68)
|
(190)
|
(69)
|
(149)
|
(159)
|
(126)
|
(67)
|
(54)
|
5
|
|
| Net Income (Common) |
(12)
N/A
|
(18)
-54%
|
(24)
-34%
|
(34)
-40%
|
(44)
-30%
|
(55)
-26%
|
(67)
-21%
|
(82)
-23%
|
(86)
-5%
|
(92)
-7%
|
(97)
-6%
|
(97)
0%
|
(86)
+12%
|
(89)
-4%
|
(92)
-3%
|
(92)
+0%
|
(107)
-16%
|
(99)
+7%
|
(95)
+4%
|
(78)
+18%
|
(73)
+7%
|
(70)
+3%
|
(66)
+6%
|
(76)
-15%
|
(90)
-18%
|
(89)
+1%
|
(105)
-17%
|
(132)
-26%
|
(34)
+74%
|
(66)
-94%
|
(87)
-32%
|
(103)
-19%
|
(231)
-124%
|
(250)
-8%
|
(265)
-6%
|
(153)
+42%
|
(141)
+8%
|
(114)
+19%
|
(83)
+27%
|
(162)
-96%
|
(25)
+84%
|
0
N/A
|
73
+53 540%
|
86
+18%
|
5
-94%
|
|
| EPS (Diluted) |
-2.34
N/A
|
-9.51
-306%
|
-12.71
-34%
|
-77.78
-512%
|
-22.36
+71%
|
-46.55
-108%
|
-33.94
+27%
|
-41.34
-22%
|
-42.71
-3%
|
-45.96
-8%
|
-48.23
-5%
|
-48.25
0%
|
-42.32
+12%
|
-44.19
-4%
|
-45.2
-2%
|
-45.05
+0%
|
-52.25
-16%
|
-48.56
+7%
|
-46.48
+4%
|
-34.7
+25%
|
-20.81
+40%
|
-24.81
-19%
|
-18.58
+25%
|
-20.67
-11%
|
-21.46
-4%
|
-22.34
-4%
|
-22.88
-2%
|
-28.87
-26%
|
-7.12
+75%
|
-14.3
-101%
|
-18.82
-32%
|
-22.36
-19%
|
-37.76
-69%
|
-46.29
-23%
|
-42.06
+9%
|
-23.63
+44%
|
-22.02
+7%
|
-17.76
+19%
|
-11.31
+36%
|
-21.39
-89%
|
-3.33
+84%
|
0.01
N/A
|
8.37
+83 600%
|
9.83
+17%
|
0.61
-94%
|
|